Introduction. When treating patients in childhood and adolescence, control over adherence to treatment falls entirely on the parents. In this regard, the information about medicinal products that the patient receives from pharmaceutical specialists is of particular value. The aim. To assess the awareness of pharmaceutical specialists in the Smolensk region about antihypertensive drugs used in children and adolescents. Materials and methods. In 2020, a sociological study was conducted by the method of anonymous questioning among the employees of pharmacies in the Smolensk region. The work design is a prospective study. Results. The study involved 109 pharmaceutical workers, of which 95.4% are women, aged 35 years, with a higher pharmaceutical education and a specialty in pharmacy. Most of the respondents had 5 to 10 years of work experience as a pharmacist. Pharmacy employees prefer reliable information sources in 84.4% of cases. When self-assessing the degree of familiarity of specialists with the group of antihypertensive drugs, the average score of the respondents was 3.8. 57.7% of the surveyed respondents correctly indicated all groups of antihypertensive drugs. Conclusion. When assessing the awareness of pharmaceutical specialists in the Smolensk region about antihypertensive drugs used in children and adolescents, it was found that there is insufficient knowledge of the range of these groups and the importance of additional education for pharmaceutical workers in this area.
{"title":"ASSESSMENT OF THE INFORMATION OF PHARMACEUTICAL SPECIALISTS OF THE SMOLENSK REGION ABOUT DRUGS USED IN CHILDREN AND ADOLESCENTS WITH ARTERIAL HYPERTENSION","authors":"O. Mikhailova, А.V. Krikova","doi":"10.30809/solo.1.2022.4","DOIUrl":"https://doi.org/10.30809/solo.1.2022.4","url":null,"abstract":"Introduction. When treating patients in childhood and adolescence, control over adherence to treatment falls entirely on the parents. In this regard, the information about medicinal products that the patient receives from pharmaceutical specialists is of particular value. The aim. To assess the awareness of pharmaceutical specialists in the Smolensk region about antihypertensive drugs used in children and adolescents. Materials and methods. In 2020, a sociological study was conducted by the method of anonymous questioning among the employees of pharmacies in the Smolensk region. The work design is a prospective study. Results. The study involved 109 pharmaceutical workers, of which 95.4% are women, aged 35 years, with a higher pharmaceutical education and a specialty in pharmacy. Most of the respondents had 5 to 10 years of work experience as a pharmacist. Pharmacy employees prefer reliable information sources in 84.4% of cases. When self-assessing the degree of familiarity of specialists with the group of antihypertensive drugs, the average score of the respondents was 3.8. 57.7% of the surveyed respondents correctly indicated all groups of antihypertensive drugs. Conclusion. When assessing the awareness of pharmaceutical specialists in the Smolensk region about antihypertensive drugs used in children and adolescents, it was found that there is insufficient knowledge of the range of these groups and the importance of additional education for pharmaceutical workers in this area.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114468846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
One of the foundations of the organization's management is to ensure its security. Currently, the topic of personnel security is increasingly interested in managers, directors, managers who use scientifically based methods of personnel management in their work. In this regard, for the normal functioning and development of a pharmaceutical organization, it is important to identify the most urgent threats to personnel security, analyze the causes of their occurrence, determine their level and assess the current state of personnel security of a pharmaceutical organization, as well as the formation of a methodology for their prevention or leveling. The purpose of this work is to study threats to personnel security, identify the main threats to the personnel security of pharmaceutical organizations, establish their significance, and develop a methodology for assessing the level of personnel security. As a result of the research, we formulated the concepts of personnel security of pharmaceutical organizations and threats to personnel security of pharmaceutical organizations. The main threats to the personnel security of pharmaceutical industry organizations have been identified, a quantitative expert assessment of the significance of threats to personnel security has been carried out, numerical values of the weighting coefficients of threats to personnel security have been calculated.
{"title":"RESULTS OF THE STUDY OF THREATS TO THE PERSONNEL SECURITY OF PHARMACEUTICAL ORGANIZATIONS","authors":"M. Y. Klishchenko, D. Kuznetsov","doi":"10.30809/solo.1.2022.3","DOIUrl":"https://doi.org/10.30809/solo.1.2022.3","url":null,"abstract":"One of the foundations of the organization's management is to ensure its security. Currently, the topic of personnel security is increasingly interested in managers, directors, managers who use scientifically based methods of personnel management in their work. In this regard, for the normal functioning and development of a pharmaceutical organization, it is important to identify the most urgent threats to personnel security, analyze the causes of their occurrence, determine their level and assess the current state of personnel security of a pharmaceutical organization, as well as the formation of a methodology for their prevention or leveling. The purpose of this work is to study threats to personnel security, identify the main threats to the personnel security of pharmaceutical organizations, establish their significance, and develop a methodology for assessing the level of personnel security. As a result of the research, we formulated the concepts of personnel security of pharmaceutical organizations and threats to personnel security of pharmaceutical organizations. The main threats to the personnel security of pharmaceutical industry organizations have been identified, a quantitative expert assessment of the significance of threats to personnel security has been carried out, numerical values of the weighting coefficients of threats to personnel security have been calculated.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124446886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. G. Petrov, N. V. Abramov, V. Kashtalap, G. Glembotskaya, I. G. Tantsereva, A.A. Maryin, E. B. Grigorieva
Patients who have had myocardial infarction (MI) represent a group of patients with a very high risk of cardiovascular complications: first of all, recurrent myocardial infarction, chronic heart failure and cardiovascular death. Clinical studies have shown an increase in life expectancy after MI when prescribing selective β-blockers for long-term prophylaxis, especially in the presence of chronic heart failure complicating the course of MI. The main clinical goals of prescribing β-blockers are to improve the supply of oxygen to the myocardium and to prevent the development of life-threatening cardiac arrhythmias. In view of the above, drugs in this group should be used indefinitely in patients with MI [7]. In recent years, the analysis of the affordability of the use of treatment technologies, including for cardiovascular diseases (CVD), has stood out as a serious scientific area with its methodology, scientific tools and is currently an important source of information that helps in making management decisions in healthcare [3.6]. The purpose of this article was to conduct such an analysis in relation to the use of β-blockers in MI in Kuzbass.
{"title":"ANALYSIS OF MEDICAL PURPOSES ANDPRICE AVAILABILITY OF THE ASSORTMENT OF BETA-ADRENOBLOCKERS USED FOR THE TREATMENT OF MYOCARDIAL INFARCTION","authors":"A. G. Petrov, N. V. Abramov, V. Kashtalap, G. Glembotskaya, I. G. Tantsereva, A.A. Maryin, E. B. Grigorieva","doi":"10.30809/solo.4.2021.2","DOIUrl":"https://doi.org/10.30809/solo.4.2021.2","url":null,"abstract":"Patients who have had myocardial infarction (MI) represent a group of patients with a very high risk of cardiovascular complications: first of all, recurrent myocardial infarction, chronic heart failure and cardiovascular death. Clinical studies have shown an increase in life expectancy after MI when prescribing selective β-blockers for long-term prophylaxis, especially in the presence of chronic heart failure complicating the course of MI. The main clinical goals of prescribing β-blockers are to improve the supply of oxygen to the myocardium and to prevent the development of life-threatening cardiac arrhythmias. In view of the above, drugs in this group should be used indefinitely in patients with MI [7]. In recent years, the analysis of the affordability of the use of treatment technologies, including for cardiovascular diseases (CVD), has stood out as a serious scientific area with its methodology, scientific tools and is currently an important source of information that helps in making management decisions in healthcare [3.6]. The purpose of this article was to conduct such an analysis in relation to the use of β-blockers in MI in Kuzbass.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114630495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The article analyzes the results of monitoring the availability and quality of the drug supply system among the population of various age groups and financial situation. The purpose of this study is to study the satisfaction of citizens in the drug supply system in Russia and to build a medical and social portrait of the patient, which was developed based on the analysis of the results of a sociological survey conducted in dynamics for 2019-2021. In the course of the research, such methods as: sociological, study and generalization of experience, analytical, methods of descriptive statistics were used. The results of the sociological study indicate the need for additional work to improve the availability and quality of LLR and the level of awareness of patients about the system of drug reimbursement. The obtained data can be used for health management bodies at various hierarchical levels, confirm the special social significance of solving this problem and the need to introduce preventive measures to involve patients in healthy lifestyle, increase public confidence in domestic drugs.
{"title":"RESULTS OF THE STUDY OF PUBLIC SATISFACTION ABOUT THEAVAILABILITY AND QUALITY OF THE DRUG SUPPLY SYSTEM IN RUSSIA","authors":"E. Telnova, A. Belova, A. A. Zagoruichenko","doi":"10.30809/solo.4.2021.1","DOIUrl":"https://doi.org/10.30809/solo.4.2021.1","url":null,"abstract":"The article analyzes the results of monitoring the availability and quality of the drug supply system among the population of various age groups and financial situation. The purpose of this study is to study the satisfaction of citizens in the drug supply system in Russia and to build a medical and social portrait of the patient, which was developed based on the analysis of the results of a sociological survey conducted in dynamics for 2019-2021. In the course of the research, such methods as: sociological, study and generalization of experience, analytical, methods of descriptive statistics were used. The results of the sociological study indicate the need for additional work to improve the availability and quality of LLR and the level of awareness of patients about the system of drug reimbursement. The obtained data can be used for health management bodies at various hierarchical levels, confirm the special social significance of solving this problem and the need to introduce preventive measures to involve patients in healthy lifestyle, increase public confidence in domestic drugs.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125249129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pain syndrome of various origins and varying intensity is the most common and leading reason for seeking medical care in the world. The main drugs for the relief of both acute and chronic pain syndrome from the 20th century to the present are non- steroidal anti-inflammatory drugs (NSAIDs). More than 30 million people worldwide receive them every day. Along with pain, other common indications for NSAIDs are fever and inflammation. All NSAIDs differ in the degree of effectiveness, form of release, speed of onset of clinical effect and dosage. That is why one of the fundamental tasks of the pharmacist, in the framework of pharmacy counseling, is to provide the patient with quality medicines and teach them how to use them rationally. With the rapid development of medical and information technologies in the modern world, the fulfillment of this task becomes more and more important, complex and responsible action. The appearance, on the pharmaceutical market innovative NSAIDs in accelerated-release dosage’s forms (for example, Ketorol® Express), makes it possible to expand the pharmacy list.
{"title":"PHARMACY CONSULTING: NEW DRUG FORMS AND NEW OPPORTUNITIES","authors":"E. E. Arinina","doi":"10.30809/solo.4.2021.4","DOIUrl":"https://doi.org/10.30809/solo.4.2021.4","url":null,"abstract":"Pain syndrome of various origins and varying intensity is the most common and leading reason for seeking medical care in the world. The main drugs for the relief of both acute and chronic pain syndrome from the 20th century to the present are non- steroidal anti-inflammatory drugs (NSAIDs). More than 30 million people worldwide receive them every day. Along with pain, other common indications for NSAIDs are fever and inflammation. All NSAIDs differ in the degree of effectiveness, form of release, speed of onset of clinical effect and dosage. That is why one of the fundamental tasks of the pharmacist, in the framework of pharmacy counseling, is to provide the patient with quality medicines and teach them how to use them rationally. With the rapid development of medical and information technologies in the modern world, the fulfillment of this task becomes more and more important, complex and responsible action. The appearance, on the pharmaceutical market innovative NSAIDs in accelerated-release dosage’s forms (for example, Ketorol® Express), makes it possible to expand the pharmacy list.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121167547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose of the study: to analyze the current state of Internet pharmacy websites in terms of compliance with Good Pharmacy Prac- tice requirements for pharmaceutical counseling for OTC-medicines. Methods. The study used the method of content analysis; a search was carried out in the search engines Google and Yandex for the keywords, «buy a pharmacy», «a drug store to buy a drug», «online pharmacy». TOP 25 pharma- cy websites were subjected to logical, comparative and structural analysis. The study consisted of 2 stages: an anal- ysis of the requirements of regulatory documents for pharmaceutical consulting when selling OTC drugs and an as- sessment of pharmacy websites in terms of ensuring compliance with these requirements when carrying out online commerce. Results. Studies of online pharmacy websites showed that most of the sites did not fully comply with the regulated require- ments: a pharmaceutical license is presented on 80% of sites, information on the type of pharmacy organization, on the impossibility of returning and exchanging pharmacy goods - on 76% of sites. The choice of OTC drugs based on symptoms within the framework of responsible self-medication was available on 24% of Internet pharmacy sites, but there were no indications of symptoms requiring immediate medical attention. Links to the State Register of Maximum Selling Prices were available on 8% of Internet pharmacy sites. Conclusion. Comparative analysis of information requirements in relation to pharmaceutical consulting in a pharmacy, reg- ulated by Orders of the Ministry of Health of Russia No. 80 «On approval of the Industry standard» Rules for the dispensing (sale) of medicines in pharmacies. Basic provisions «and No. 647n dated 31.08.2016» On approval of the Rules Good Pharma- cy Practice of Medicinal Products for Medical Use ”, Government Decree No. 697 of May 16, 2020“ On Approval of the Rules for Issuing Permits for Remote Retail Sale of Medicinal Products for Medical Use, Implementation of Such Trade ... ”, showed that most of the requirements for offline pharmacy were reflected in relation to Internet pharmacies, however, as a result of the analysis of Internet pharmacy websites, it was found that these requirements are not fully met. Additional criteria for evaluating online pharmacy sites corresponding to the level of pharmaceutical care in an offline pharmacy are proposed: the ability to select an OTC drug by symptoms within the framework of responsible self-medication, the presence of indications of symptoms that require immediate medical attention, the presence of instructions for the medical use of the drug in in ac- cordance with the State Register of Medicines, ensuring access to the State Register of maximum selling prices, availability of information on the actual shelf life of the medicinal products being sold.
{"title":"ANALYSIS OF COMPLIANCE WITH THE REQUIREMENTS OF GOOD PHARMACY PRACTICE FOR PHARMACEUTICAL CONSULTINGWHEN CHOOSING OTC DRUGS ON THE WEBSITES OF ONLINE PHARMACIES","authors":"I.E. Lukoianova, S. N. Egorova","doi":"10.30809/solo.3.2021.2","DOIUrl":"https://doi.org/10.30809/solo.3.2021.2","url":null,"abstract":"Purpose of the study: to analyze the current state of Internet pharmacy websites in terms of compliance with Good Pharmacy Prac- tice requirements for pharmaceutical counseling for OTC-medicines. Methods. The study used the method of content analysis; a search was carried out in the search engines Google and Yandex for the keywords, «buy a pharmacy», «a drug store to buy a drug», «online pharmacy». TOP 25 pharma- cy websites were subjected to logical, comparative and structural analysis. The study consisted of 2 stages: an anal- ysis of the requirements of regulatory documents for pharmaceutical consulting when selling OTC drugs and an as- sessment of pharmacy websites in terms of ensuring compliance with these requirements when carrying out online commerce. Results. Studies of online pharmacy websites showed that most of the sites did not fully comply with the regulated require- ments: a pharmaceutical license is presented on 80% of sites, information on the type of pharmacy organization, on the impossibility of returning and exchanging pharmacy goods - on 76% of sites. The choice of OTC drugs based on symptoms within the framework of responsible self-medication was available on 24% of Internet pharmacy sites, but there were no indications of symptoms requiring immediate medical attention. Links to the State Register of Maximum Selling Prices were available on 8% of Internet pharmacy sites. Conclusion. Comparative analysis of information requirements in relation to pharmaceutical consulting in a pharmacy, reg- ulated by Orders of the Ministry of Health of Russia No. 80 «On approval of the Industry standard» Rules for the dispensing (sale) of medicines in pharmacies. Basic provisions «and No. 647n dated 31.08.2016» On approval of the Rules Good Pharma- cy Practice of Medicinal Products for Medical Use ”, Government Decree No. 697 of May 16, 2020“ On Approval of the Rules for Issuing Permits for Remote Retail Sale of Medicinal Products for Medical Use, Implementation of Such Trade ... ”, showed that most of the requirements for offline pharmacy were reflected in relation to Internet pharmacies, however, as a result of the analysis of Internet pharmacy websites, it was found that these requirements are not fully met. Additional criteria for evaluating online pharmacy sites corresponding to the level of pharmaceutical care in an offline pharmacy are proposed: the ability to select an OTC drug by symptoms within the framework of responsible self-medication, the presence of indications of symptoms that require immediate medical attention, the presence of instructions for the medical use of the drug in in ac- cordance with the State Register of Medicines, ensuring access to the State Register of maximum selling prices, availability of information on the actual shelf life of the medicinal products being sold.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123487245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Tolkushin, M. Hołownia-Voloskova, E. A. Luchinin, A. Zavyalov
{"title":"REVIEW OF DRUG CONSUMPTION WITHIN THEFRAMEWORK OF PREFERENTIAL DRUG PROVISION FOR PATIENTS WITH CERTAIN MALIGNANT NEOPLASMS OF LYMPHATIC AND HEMATOPOIETIC TISSUES IN MOSCOW IN 2019","authors":"A. Tolkushin, M. Hołownia-Voloskova, E. A. Luchinin, A. Zavyalov","doi":"10.30809/solo.3.2021.3","DOIUrl":"https://doi.org/10.30809/solo.3.2021.3","url":null,"abstract":"","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121777065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Egorova, L. N. Sheikhmambetova, K. Onishchenko, E. Bekirova, A. Zakharova
Abstract. In the structure of the total morbidity of the Russian Federation population in 2018, skin and subcutaneous adipose tissue diseases made about 3,5 of the total number of cases, which amounted to 8330 thousand registered cases of diseases. The purpose of the research was to analyze the expenditure of material resources allocated for drug provision of the State Budgetary Institution of Healthcare of the Republic of Crimea “Clinical Dermatovenerologic Dispensary” (SBIH RC “CDVD”) for the period from January 1, 2020 to December 31, 2020. Materials and Methods. Based on the data obtained from the Statistical Department of SBIH RC “CDVD” on the financial means expenditures on the purchase of drugs, an assessment of the budgetary funds expenditures was carried out by means of ABC/VEN analysis. Results and discussion. According to the data received, for the period from January 1, 2020 to December 31, 2020, 3 156 patients were admitted to inpatient departments. 9, 072, 064, 00 rubles were spent on the treatment of patients’ nosologies, while the list of all drugs used included 98 names. The ABC analysis showed the feasibility of spending monetary resources, which confirms the lack of “N”- category (minor) drugs among “A” – category drugs (80% of the budget). The results of VEN-analysis indicated that 50% of the drugs used are referred to “V” category, which indicates that the Healthcare Institution predominantly purchased vital drugs. Conclusion. Active implementation of the methodology of management of medical care with help of modern technologies of ABC- and VEN- analyses allows timely implementation of measures to rationalize drug procurement in inpatient and outpatient healthcare institutions, as well as the choice of drugs for inclusion into the formulary and treatment standards.
摘要。在2018年俄罗斯联邦人口总发病率结构中，皮肤和皮下脂肪组织疾病约占病例总数的3.5，达到833万登记病例。本研究的目的是分析克里米亚共和国国家卫生预算机构“临床皮肤性病药房”(SBIH RC“CDVD”)在2020年1月1日至2020年12月31日期间分配用于药物供应的物质资源支出。材料与方法。根据上海卫生研究院“CDVD”统计部门关于药品采购财务手段支出的数据，采用ABC/VEN分析法对预算资金支出进行评估。结果和讨论。根据收到的数据，2020年1月1日至2020年12月31日，住院科室收治患者3156例。用于治疗病人疾病的费用为9072 064 000卢布，而使用的所有药物的清单包括98个名字。ABC分析显示了花费资金资源的可行性，这证实了A类药物中缺少N类(次要)药物(占预算的80%)。vin分析结果表明，50%的药物被称为" V "类，这表明医疗机构主要购买的是至关重要的药物。结论。在ABC和VEN分析的现代技术的帮助下，积极实施医疗保健管理方法，可以及时实施措施，使住院和门诊医疗机构的药品采购合理化，以及选择纳入处方和治疗标准的药物。
{"title":"RESEARCH OF THE FEATURES OF DRUG PROVISION OF THE REPUBLICAN DERMATOVENEROLOGIC SIMFEROPOL DISPENSARY","authors":"E. Egorova, L. N. Sheikhmambetova, K. Onishchenko, E. Bekirova, A. Zakharova","doi":"10.30809/solo.2.2021.1","DOIUrl":"https://doi.org/10.30809/solo.2.2021.1","url":null,"abstract":"Abstract. In the structure of the total morbidity of the Russian Federation population in 2018, skin and subcutaneous adipose tissue diseases made about 3,5 of the total number of cases, which amounted to 8330 thousand registered cases of diseases. The purpose of the research was to analyze the expenditure of material resources allocated for drug provision of the State Budgetary Institution of Healthcare of the Republic of Crimea “Clinical Dermatovenerologic Dispensary” (SBIH RC “CDVD”) for the period from January 1, 2020 to December 31, 2020. Materials and Methods. Based on the data obtained from the Statistical Department of SBIH RC “CDVD” on the financial means expenditures on the purchase of drugs, an assessment of the budgetary funds expenditures was carried out by means of ABC/VEN analysis. Results and discussion. According to the data received, for the period from January 1, 2020 to December 31, 2020, 3 156 patients were admitted to inpatient departments. 9, 072, 064, 00 rubles were spent on the treatment of patients’ nosologies, while the list of all drugs used included 98 names. The ABC analysis showed the feasibility of spending monetary resources, which confirms the lack of “N”- category (minor) drugs among “A” – category drugs (80% of the budget). The results of VEN-analysis indicated that 50% of the drugs used are referred to “V” category, which indicates that the Healthcare Institution predominantly purchased vital drugs. Conclusion. Active implementation of the methodology of management of medical care with help of modern technologies of ABC- and VEN- analyses allows timely implementation of measures to rationalize drug procurement in inpatient and outpatient healthcare institutions, as well as the choice of drugs for inclusion into the formulary and treatment standards.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114663159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. A. Pavluchenkova, A. Mikheeva, E. A. Sakharitova
The spread of multidrug-resistant and extensively drug-resistant tuberculosis (MDR and XDR) requires the search and implementation of not only new diagnostic methods, but also innovations in the treatment of the disease. Aim. The assessment of current treatment options for multidrug-resistant tuberculosis in different countries. Materials and Methods. There was carried out the content analysis of the official sources of 24 countries concerning the drugs that had been registered at these countries and recommended by the World Health Organization for the treatment of multidrug-resistant tuberculosis and put into circulation from 2000 to 2020: linezolid, bedaquiline, delamanid, clofazimine (as of 07.2020). The data were compared with the characteristics of the epidemiological situation in the country. Results. There was developed a six-digit classification by the following criteria: the presence of international nonproprietary names for drugs; the availability and range of dosage forms; the number of drugs subject to all dosage forms, dosages, pharmaceutical forms and units of packaging; the presence in the domestic market of the original product; the time of registration of drugs in the specified territory; the level of multi-drug resistance of the pathogen in the country per 100,000 population. Among the countries with the highest market coverage with a low (up to 0.5 per 100 thousand) level of multidrug resistance, a large share falls on European countries. As for a number of African States, there may be a threat of spreading the disease taking into account the epidemiological situation for multidrug-resistant tuberculosis and with only linezolid registered. The list of countries with a level of the same indicator above 15 per 100,000 population includes Russia and Namibia with radically different market characteristics. If Russia possesses the entire available range of medicines with the number of nomenclature items above 200, then Namibia has no more than 10 linezolid preparations registered only in tablet form. The main supplier of innovative products in the field of tuberculosis control is the Asia-Pacific region. Сonclusion. It is defined that the characteristics of the drug market differ significantly depending on the economic development of states and are determined by the indicator of the disease burden. Success in the tuberculosis control is impossible without the active development of the pharmaceutical industry and the replenishment of the market with innovative products.
{"title":"АSSESSMENT OF THE PRODUCTIVE AND RESOURCE CAPABILITIES OF COUNTRIES FOR MULTIDRUG-RESISTANT TUBERCULOSIS CONTROL","authors":"N. A. Pavluchenkova, A. Mikheeva, E. A. Sakharitova","doi":"10.30809/solo.2.2021.2","DOIUrl":"https://doi.org/10.30809/solo.2.2021.2","url":null,"abstract":"The spread of multidrug-resistant and extensively drug-resistant tuberculosis (MDR and XDR) requires the search and implementation of not only new diagnostic methods, but also innovations in the treatment of the disease. Aim. The assessment of current treatment options for multidrug-resistant tuberculosis in different countries. Materials and Methods. There was carried out the content analysis of the official sources of 24 countries concerning the drugs that had been registered at these countries and recommended by the World Health Organization for the treatment of multidrug-resistant tuberculosis and put into circulation from 2000 to 2020: linezolid, bedaquiline, delamanid, clofazimine (as of 07.2020). The data were compared with the characteristics of the epidemiological situation in the country. Results. There was developed a six-digit classification by the following criteria: the presence of international nonproprietary names for drugs; the availability and range of dosage forms; the number of drugs subject to all dosage forms, dosages, pharmaceutical forms and units of packaging; the presence in the domestic market of the original product; the time of registration of drugs in the specified territory; the level of multi-drug resistance of the pathogen in the country per 100,000 population. Among the countries with the highest market coverage with a low (up to 0.5 per 100 thousand) level of multidrug resistance, a large share falls on European countries. As for a number of African States, there may be a threat of spreading the disease taking into account the epidemiological situation for multidrug-resistant tuberculosis and with only linezolid registered. The list of countries with a level of the same indicator above 15 per 100,000 population includes Russia and Namibia with radically different market characteristics. If Russia possesses the entire available range of medicines with the number of nomenclature items above 200, then Namibia has no more than 10 linezolid preparations registered only in tablet form. The main supplier of innovative products in the field of tuberculosis control is the Asia-Pacific region. Сonclusion. It is defined that the characteristics of the drug market differ significantly depending on the economic development of states and are determined by the indicator of the disease burden. Success in the tuberculosis control is impossible without the active development of the pharmaceutical industry and the replenishment of the market with innovative products.","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121290364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. N. Sheikhmambetova, E. Egorova, E. Bekirova, K. Onishchenko
Some of the most widespread illnesses of alimentary canal are the stomach (gastric) ulcer, duodenal ulcer disease, gastroesophageal reflux diseases. The ethanol of antisecretory treatment of the given acid-dependent diseases are the preparations of the proton pump inhibitor group with omeprazole which is considered to be more effective and investigated. The goal of the research is the oral medications omeprazole (20 mg) assortment market investigation. Materials and methods. The research objects are the State register of medicines data of oral medicinal products including omeprazole dosing 20 mg recorded on the pharmaceutical market as well as the State price register data on the vital medicinal products on April, 4, 2021. Results. According to the SRMP 30 trade names of medicinal products including omeprazole dosing 20 mg as active ingredient in capsules and tablets are registered on the pharmaceutical market in Russian Federation. The omeprazole products distribution in the countries holding registration certificates showed the predominance of domestic production medicinal products (18 trade names, 60 %). The cost analysis of standard daily and course dose oral omeprazole form (20 mg) of different trade names allowed to select economically profitable preparations (”Omeprazole”, LLC “Production of Medicines”, Russia; “Omeprazole”, OJSC ‘‘Synthesis”, Russia; “Omeprazole” LLC BFMP, Russia), the insert of which into the list of medicines to provide the gastroesophageal reflux disease and stomach (gastric) ulcer patients at the regional level is economically feasible as well the medicines with the high price (Losec MUPS AstraZeneca AB, Sweden). Сonclusion. The results of the pharmaceutical market research of oral omeprazole form (20mg) indicates a great majority of generic medicine, a sufficient market capacity, medicine predominance of domestic production (60%).
{"title":"MARKETING STUDY OF ORAL FORMS OF OMEPRAZOLE PREPARATIONS USED FOR THE TREATMENT AND PREVENTION OF GASTROESOPHAGEAL REFLUX DISEASE AND GASTRIC ULCER","authors":"L. N. Sheikhmambetova, E. Egorova, E. Bekirova, K. Onishchenko","doi":"10.30809/solo.2.2021.3","DOIUrl":"https://doi.org/10.30809/solo.2.2021.3","url":null,"abstract":"Some of the most widespread illnesses of alimentary canal are the stomach (gastric) ulcer, duodenal ulcer disease, gastroesophageal reflux diseases. The ethanol of antisecretory treatment of the given acid-dependent diseases are the preparations of the proton pump inhibitor group with omeprazole which is considered to be more effective and investigated. The goal of the research is the oral medications omeprazole (20 mg) assortment market investigation. Materials and methods. The research objects are the State register of medicines data of oral medicinal products including omeprazole dosing 20 mg recorded on the pharmaceutical market as well as the State price register data on the vital medicinal products on April, 4, 2021. Results. According to the SRMP 30 trade names of medicinal products including omeprazole dosing 20 mg as active ingredient in capsules and tablets are registered on the pharmaceutical market in Russian Federation. The omeprazole products distribution in the countries holding registration certificates showed the predominance of domestic production medicinal products (18 trade names, 60 %). The cost analysis of standard daily and course dose oral omeprazole form (20 mg) of different trade names allowed to select economically profitable preparations (”Omeprazole”, LLC “Production of Medicines”, Russia; “Omeprazole”, OJSC ‘‘Synthesis”, Russia; “Omeprazole” LLC BFMP, Russia), the insert of which into the list of medicines to provide the gastroesophageal reflux disease and stomach (gastric) ulcer patients at the regional level is economically feasible as well the medicines with the high price (Losec MUPS AstraZeneca AB, Sweden). Сonclusion. The results of the pharmaceutical market research of oral omeprazole form (20mg) indicates a great majority of generic medicine, a sufficient market capacity, medicine predominance of domestic production (60%).","PeriodicalId":266512,"journal":{"name":"Modern organization of drug supply","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132456465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：